ID TRANSFAC | Gene symbol | Yes/no ratio | P | Involvement in cancer types other than HCC | Involvement in HCC |
---|---|---|---|---|---|
V$AR_03 | AR | 14.1 | 2.39E−02 | Tumour promoting [23] | Tumour promoting [24] |
V$TFIIA_Q6 | GTF2A1/GTF2A2 | 8.5 | 1.25E−02 | General enhancement of gene transcription [25] | – |
V$PR_01 | PGR | 7.1 | 5.47E−02 | Tumour promoting [26] | Unclear [27] |
V$HES1_Q2 | HES1 | 7.1 | 1.79E−02 | Tumour promoting [28] | Unknown |
V$ZNF219_01 | ZNF219 | 4.4 | 3.10E−14 | Unknown | Unknown |
V$AREB6_03 | ZEB1 | 4 | 4.24E−03 | Tumour promoting [29] | |
V$GCNF_01 | NR6A1 | 3.2 | 2.99E−02 | Tumour promoting [32] | Unknown |
V$MAZR_01 | PATZ1 | 2.7 | 2.16E−50 | Tumour promoting [33] | Unknown |
V$PAX4_04 | PAX4 | 2.7 | 3.70E−02 | Cell proliferation/survival promoting or tumour suppressing in different contexts [34] | Unknown |
V$UF1H3BETA_Q6 | UF1-HNF3B (not further identified) | 2.6 | 3.09E−74 | – | – |
V$CACBINDINGPROTEIN_Q6 | CAC-binding protein (not further identified) | 2.5 | 1.87E−26 | – | – |
V$MTF1_Q4 | MTF1 | 2.5 | 3.30E−04 | Tumour promoting [35] | Unknown |